<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03326960</url>
  </required_header>
  <id_info>
    <org_study_id>dsyy002</org_study_id>
    <nct_id>NCT03326960</nct_id>
  </id_info>
  <brief_title>Sevoflurane, Propofol and Desflurane on POD/POCD</brief_title>
  <official_title>Effects of Anesthetics Sevoflurane, Propofol and Desflurane on Postoperative Delirium (POD) and Postoperative Cognitive Disorder (POCD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai 10th People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Shanghai 10th People's Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will perform clinical studies to test the hypothesis that participants who
      have total hip/knee replacement under sevoflurane, propofol or desflurane anesthesia will
      have different effects on the incidence and severity of POD/POCD, and POD/POCD is associated
      with retinal nerve fiber layer (RNFL) thickness, as well as Serum level of vitamin B12, folic
      acid, homocysteine and human myeloid differentiation protein-2 (MD-2s). The investigators
      plan to perform the studies in 300 participants at Shanghai 10th People's Hospital.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Postoperative delirium (POD) and postoperative cognitive disorder (POCD) are the most common
      complications of geriatric surgical patients, which could cause long-term social dysfunction,
      high mortality and increased medical cost. Currently, there is no efficient biomarker for
      POD/POCD, and it also remains largely unknown whether different anesthesia might lead to
      different incidence and severity of POD/POCD. The investigator's previous studies showed that
      thickness of retinal nerve fiber layer thickness (RNFL-T) measured by optical coherence
      tomography (OCT) was associated with POD/POCD; change of RNFL thickness (RNFL-C) in certain
      period correlated with cognitive deterioration. Thus, the investigators consider that RNFL
      might be a potential biomarker of POD/POCD. In the proposed large-scale longitudinal studies,
      the investigators will clinically validate RNF-LT as pre-operative POD/POCD biomarker, and
      RNFL-C as post-operative biomarker of POD/POCD. Finally, the investigators will compare the
      effects of surgery (total hip/knee replacement) under general anesthesia with sevoflurane,
      propofol and desflurane on the incidence and severity of POD/POCD in patients. Results from
      the proposed studies will likely establish RNFL as a potential POD/POCD biomarker, promote
      the clinical utilization of OCT-RNFL in early screening and outcome prediction of POD/POCD,
      and finally optimize anesthesia care of geriatric surgical patients to avoid or reduce
      POD/POCD incidence. These findings will lead to better postoperative outcomes of geriatric
      patients.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2016</start_date>
  <completion_date type="Anticipated">June 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative delirium</measure>
    <time_frame>At 1st day after the surgery</time_frame>
    <description>Postoperative delirium will be determined by Confusion Assessment Method (CAM) at 1st postoperative day</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative delirium</measure>
    <time_frame>At 2nd day after the surgery</time_frame>
    <description>Postoperative delirium will be determined by CAM at 2nd postoperative day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative delirium</measure>
    <time_frame>At 3rd day after the surgery</time_frame>
    <description>Postoperative delirium will be determined by CAM at 3rd postoperative day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Preoperative cognitive function</measure>
    <time_frame>Preoperative cognitive function (baseline)</time_frame>
    <description>Preoperative cognitive function will be assessed by neuropsychological battery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative cognitive dysfunction</measure>
    <time_frame>Change from baseline cognitive dysfunction at 1 week</time_frame>
    <description>Postoperative cognitive dysfunction will be assessed by neuropsychological battery before and after the surgery and anesthesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative cognitive dysfunction</measure>
    <time_frame>Change from baseline cognitive dysfunction at 3rd month</time_frame>
    <description>Postoperative cognitive dysfunction will be assessed by neuropsychological battery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Retinal nerve fiber layer thickness</measure>
    <time_frame>Change from baseline RNFL thickness at 3rd month</time_frame>
    <description>Retinal nerve fiberlayer（RNFL）thickness will be measured by optical coherence tomography (OCT) before and after surgery and anesthesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum level of vitamin B12, folic acid, homocysteine and myeloid differentiation protein-2 (MD-2s)</measure>
    <time_frame>Before the surgery (baseline)</time_frame>
    <description>vitamin B12, folic acid, homocysteine and myeloid differentiation protein-2 (MD-2s) will be tested</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum level of vitamin B12, folic acid, homocysteine and myeloid differentiation protein-2 (MD-2s)</measure>
    <time_frame>At 1st day after the surgery</time_frame>
    <description>vitamin B12, folic acid, homocysteine and myeloid differentiation protein-2 (MD-2s) will be tested</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum level of vitamin B12, folic acid, homocysteine and myeloid differentiation protein-2 (MD-2s)</measure>
    <time_frame>At 2nd day after the surgery</time_frame>
    <description>vitamin B12, folic acid, homocysteine and myeloid differentiation protein-2 (MD-2s) will be tested</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum level of vitamin B12, folic acid, homocysteine and myeloid differentiation protein-2 (MD-2s)</measure>
    <time_frame>At 3rd day after the surgery</time_frame>
    <description>vitamin B12, folic acid, homocysteine and myeloid differentiation protein-2 (MD-2s) will be tested</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Sevoflurane</condition>
  <condition>Propofol</condition>
  <condition>Desflurane</condition>
  <arm_group>
    <arm_group_label>Sevoflurane</arm_group_label>
    <description>Patients in Sevoflurane group are maintained with sevoflurane from an anesthesia machine through the laryngeal mask airway guided by Narcrotrend index monitoring.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Propofol</arm_group_label>
    <description>Patients in Propofol group are maintained with propofol through intravenous administration guided by Narcrotrend index monitoring.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Desflurane</arm_group_label>
    <description>Patients in Desflurane group are maintained with desflurane from an anesthesia machine through the laryngeal mask airway guided by Narcrotrend index monitoring.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>Anesthesia maintenance with sevoflurane guided by Narcrotrend index monitoring.</description>
    <arm_group_label>Sevoflurane</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Anesthesia maintenance with propofol guided by Narcrotrend index monitoring.</description>
    <arm_group_label>Propofol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Desflurane</intervention_name>
    <description>Anesthesia maintenance with desflurane guided by Narcrotrend index monitoring.</description>
    <arm_group_label>Desflurane</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      The investigators will collect 10ml venous blood before anesthesia, and then 10ml venous
      blood after surgery on Day 1, Day 2 and Day 3, respectively. Serum level of vitamin B12,
      folic acid, homocysteine and myeloid differentiation protein-2 (MD-2s) will be tested.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients, aged 60 years old or older, who admitted to the Department of Orthopedics at
        Shanghai 10th People's Hospital and had been scheduled to undergo knee or hip fractures
        were screened and asked to participate in the study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  60 years old or older

          -  Chinese Mandarin as the native language

          -  scheduled to undergo hip/knee surgery under general anesthesia

          -  American Society of Anesthesiologists (ASA) class I-Ⅲ

        Exclusion Criteria:

          -  Prior diagnoses of neurological diseases according to ICD-10

          -  History of severe psychiatric disorders according to DSM-IV

          -  Visual or auditory defects

          -  Participating in the investigation of another study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yuan Shen, M.D.,Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shanghai 10th People's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yuan Shen, M.D.,Ph.D.</last_name>
    <phone>66303649</phone>
    <email>kmshy@tongji.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zhongyong Shi, M.D., Ph.D.</last_name>
    <phone>18701915271</phone>
    <email>szy0721@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Shanghai 10th People's Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200072</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yanxia Guo, M.D.</last_name>
      <phone>021-65982875</phone>
      <email>guoyx_2000@tongji.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Vlisides P, Xie Z. Neurotoxicity of general anesthetics: an update. Curr Pharm Des. 2012;18(38):6232-40. Review.</citation>
    <PMID>22762477</PMID>
  </reference>
  <reference>
    <citation>Witlox J, Eurelings LS, de Jonghe JF, Kalisvaart KJ, Eikelenboom P, van Gool WA. Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: a meta-analysis. JAMA. 2010 Jul 28;304(4):443-51. doi: 10.1001/jama.2010.1013.</citation>
    <PMID>20664045</PMID>
  </reference>
  <reference>
    <citation>Gleason LJ, Schmitt EM, Kosar CM, Tabloski P, Saczynski JS, Robinson T, Cooper Z, Rogers SO Jr, Jones RN, Marcantonio ER, Inouye SK. Effect of Delirium and Other Major Complications on Outcomes After Elective Surgery in Older Adults. JAMA Surg. 2015 Dec;150(12):1134-40. doi: 10.1001/jamasurg.2015.2606.</citation>
    <PMID>26352694</PMID>
  </reference>
  <reference>
    <citation>Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Lancet. 2014 Mar 8;383(9920):911-22. doi: 10.1016/S0140-6736(13)60688-1. Epub 2013 Aug 28. Review.</citation>
    <PMID>23992774</PMID>
  </reference>
  <reference>
    <citation>Pandharipande PP, Girard TD, Jackson JC, Morandi A, Thompson JL, Pun BT, Brummel NE, Hughes CG, Vasilevskis EE, Shintani AK, Moons KG, Geevarghese SK, Canonico A, Hopkins RO, Bernard GR, Dittus RS, Ely EW; BRAIN-ICU Study Investigators. Long-term cognitive impairment after critical illness. N Engl J Med. 2013 Oct 3;369(14):1306-16. doi: 10.1056/NEJMoa1301372.</citation>
    <PMID>24088092</PMID>
  </reference>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>October 6, 2017</study_first_submitted>
  <study_first_submitted_qc>October 30, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 31, 2017</study_first_posted>
  <last_update_submitted>May 27, 2019</last_update_submitted>
  <last_update_submitted_qc>May 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 29, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai 10th People's Hospital</investigator_affiliation>
    <investigator_full_name>Yuan Shen, MD, PhD</investigator_full_name>
    <investigator_title>Head of Psychiatry</investigator_title>
  </responsible_party>
  <keyword>general anesthesia</keyword>
  <keyword>postoperative delirium</keyword>
  <keyword>postoperative cognitive dysfunction</keyword>
  <keyword>retinal nerve fiber layer</keyword>
  <keyword>biomarker</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
    <mesh_term>Desflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

